The British government has launched the AI Biosecurity Lab (AIBL) under its National AI Biosecurity Initiative, allocating £100 million, roughly $134 million, to the effort. The venture will receive backing from OpenAI, Anthropic and Google DeepSeek. AIBL will gather specialists in biosecurity and life sciences to work alongside cutting‑edge artificial intelligence, aiming to spot biological threats and speed the creation of vaccines and other medical treatments. Though it will operate as an independent, non‑profit entity, the lab plans to partner with public‑sector bodies and academic institutions.
In its statement, the government highlighted that AI is opening “unprecedented opportunities for scientific discovery” while also introducing “new biological risks and could lower barriers to harmful activity.” It cited a recent claim from a California research lab that it used AI to design a virus, which was then tested on a human patient. The virus was intended to target antibiotic‑resistant bacteria, not to cause harm, but the episode illustrates how advanced AI can be applied to biotechnology.
“The lab’s cutting‑edge research will strengthen UK and global resilience to a wide range of biological risks, including those enabled by advances in AI,” the announcement read. AI minister Kanishka Narayan added that AIBL “will be a major new global institution, bringing together world‑leading scientific expertise to protect people from emerging biological threats and ensure Britain leads the world in AI safety and security.”
OpenAI will support the project with £100 million in credits for access to its most advanced models and computing resources, while Anthropic will contribute an equal amount of model credits. The lab will also work with Google DeepMind and UK‑based AI life‑sciences firm Basecamp Research. DeepMind’s biosecurity experts will collaborate on research and provide access to its Gemini models, and Basecamp will supply AI‑biology models and technical know‑how for biosecurity challenges.